Pharma Journalist -

Swedish Orphan Biovitrum AB (Sobi) announced that it has appointed Guido Oelkers as New President and CEO who will be succeeding Geoffrey McDonough effectively from 22 May, 2017.…
Read More...

Concordian International announced that they have Itzhak Krinsky, PhD. and Francis (Frank) Perier, Jr. as members of Board of Directors. After this appointment the Board will…
Read More...

David Price has been appointed as CFO (Chief Financial Officer) of Concordia International. He will succeed Edward Borkowski and will be effective from May 15,2017. He will be reporting…
Read More...

Callery Corporation announced that it has appointed Dr. Harry Rathore as its Chief Executive Officer. Dr. Rathore holds a Ph.D. in Medicinal Chemistry from the Oregon State…
Read More...

Sandoz Canada announced the launch of Sandoz Olmesartan (olmesartan medoxomil), a generic version of OLMETEC, for the treatment of mild to moderate essential hypertension. This follows…
Read More...

Propanc Biopharma provided an update on the development of the GMP-compliant investigational medicinal product (IMP) manufacture of PRP for First-In-Human studies. PRP is a solution for…
Read More...

AMRI announced it received a 5-year federal contract award from the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), for…
Read More...

Imprimis Pharmaceuticals, an ophthalmology-focused pharmaceutical company, and SightLife Surgical, a cornea-focused organization providing comprehensive services to ophthalmic surgeons,…
Read More...

Oramed Pharmaceuticals Inc., a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced that based on positive preclinical data, the…
Read More...

Stealth BioTherapeutics Inc. (Stealth), a clinical-stage biopharmaceutical company developing therapeutics to treat mitochondrial dysfunction, today announced the initiation of…
Read More...